Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T
Maryam M. Javadpour, … , Ilka Pinz, Joanne S. Ingwall
Maryam M. Javadpour, … , Ilka Pinz, Joanne S. Ingwall
Published September 1, 2003
Citation Information: J Clin Invest. 2003;112(5):768-775. https://doi.org/10.1172/JCI15967.
View: Text | PDF
Article Cardiology

Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T

  • Text
  • PDF
Abstract

The thin filament protein cardiac troponin T (cTnT) is an important regulator of myofilament activation. Here we report a significant change in cardiac energetics in transgenic mice bearing the missense mutation R92Q within the tropomyosin-binding domain of cTnT, a mutation associated with a clinically severe form of familial hypertrophic cardiomyopathy. This functional domain of cTnT has recently been shown to be a crucial modulator of contractile function despite the fact that it does not directly interact with the ATP hydrolysis site in the myosin head. Simultaneous measurements of cardiac energetics using 31P NMR spectroscopy and contractile performance of the intact beating heart revealed both a decrease in the free energy of ATP hydrolysis available to support contractile work and a marked inability to increase contractile performance upon acute inotropic challenge in hearts from R92Q mice. These results show that alterations in thin filament protein structure and function can lead to significant defects in myocardial energetics and contractile reserve.

Authors

Maryam M. Javadpour, Jil C. Tardiff, Ilka Pinz, Joanne S. Ingwall

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Total
Citations: 1 2 3 3 1 3 2 3 6 2 4 4 2 3 4 5 4 1 3 2 2 1 61
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (61)

Title and authors Publication Year
The abnormalities of free fatty acid metabolism in patients with hypertrophic cardiomyopathy, a single-center retrospective observational study
Zhang K, Yuan Z, Wang S, Zhao S, Cui H, Lai Y
BMC Cardiovascular Disorders 2024
Suppression of lusitropy as a disease mechanism in cardiomyopathies
Marston S, Pinto JR
Frontiers in Cardiovascular Medicine 2023
Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities
Sequeira V, Waddingham MT, Tsuchimochi H, Maack C, Pearson JT
Journal of Molecular and Cellular Cardiology Plus 2023
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
Pioner JM, Vitale G, Gentile F, Scellini B, Piroddi N, Cerbai E, Olivotto I, Tardiff J, Coppini R, Tesi C, Poggesi C, Ferrantini C
Frontiers in physiology 2022
Cardiac (31)P MR spectroscopy: development of the past five decades and future vision-will it be of diagnostic use in clinics?
Gupta A
Heart Failure Reviews 2022
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy
Previs MJ, O\u2019Leary TS, Morley MP, Palmer B, LeWinter M, Yob J, Pagani FD, Petucci C, Kim MS, Margulies KB, Arany Z, Kelly DP, Day SM
Circulation. Heart failure 2022
Altered Cardiac Energetics and Mitochondrial Dysfunctionin Hypertrophic Cardiomyopathy
S Ranjbarvaziri, KB Kooiker, M Ellenberger, G Fajardo, M Zhao, AS Roest, RA Woldeyes, TT Koyano, R Fong, N Ma, L Tian, GM Traber, F Chan, J Perrino, S Reddy, W Chiu, JC Wu, JY Woo, KM Ruppel, JA Spudich, MP Snyder, K Contrepois, D Bernstein
Circulation 2021
Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
MJ Greenberg, JC Tardiff
The Journal of General Physiology 2021
Actinin BioID reveals sarcomere crosstalk with oxidative metabolism through interactions with IGF2BP2
FA Ladha, K Thakar, AM Pettinato, N Legere, S Ghahremani, R Cohn, R Romano, E Meredith, YS Chen, JT Hinson
Cell Reports 2021
Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
RY Parbhudayal, HJ Harms, M Michels, AC van Rossum, T Germans, J van der Velden
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2020
Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems
AE Deranek, MM Klass, JC Tardiff
Pflügers Archiv - European Journal of Physiology 2019
The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle
G Vitale, C Ferrantini, N Piroddi, B Scellini, JM Pioner, B Colombini, C Tesi, C Poggesi
Journal of Muscle Research and Cell Motility 2019
Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy
Y Liu, J Afzal, S Vakrou, GV Greenland, CC Talbot, VB Hebl, Y Guan, R Karmali, JC Tardiff, LA Leinwand, JE Olgin, S Das, R Fukunaga, MR Abraham
Frontiers in Cardiovascular Medicine 2019
Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models
Styliani Vakrou, Ryuya Fukunaga, D. Brian Foster, Lars Sorensen, Yamin Liu, Yufan Guan, Kirubel Woldemichael, Roberto Pineda-Reyes, Ting Liu, Jil Tardiff, Leslie Leinwand, Carlo G. Tocchetti, Theodore Abraham, Brian O'Rourke, Miguel A. Aon, M. Roselle Abraham
JCI Insight 2018
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM
N Piroddi, ER Witjas-Paalberends, C Ferrara, C Ferrantini, G Vitale, B Scellini, PJ Wijnker, V Sequiera, D Dooijes, C dos Remedios, S Schlossarek, MC Leung, A Messer, DG Ward, A Biggeri, C Tesi, L Carrier, CS Redwood, SB Marston, J van der Velden, C Poggesi
The Journal of General Physiology 2018
Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic CardiomyopathyCLINICAL PERSPECTIVE
R Coppini, L Mazzoni, C Ferrantini, F Gentile, JM Pioner, T Laurino, L Santini, V Bargelli, M Rotellini, G Bartolucci, C Crocini, L Sacconi, C Tesi, L Belardinelli, J Tardiff, A Mugelli, I Olivotto, E Cerbai, C Poggesi
Circulation. Heart failure 2017
Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy
CN Karam, CM Warren, M Henze, NH Banke, ED Lewandowski, RJ Solaro
American journal of physiology. Heart and circulatory physiology 2017
Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models
C Ferrantini, R Coppini, JM Pioner, F Gentile, B Tosi, L Mazzoni, B Scellini, N Piroddi, A Laurino, L Santini, V Spinelli, L Sacconi, PD Tombe, R Moore, J Tardiff, A Mugelli, I Olivotto, E Cerbai, C Tesi, C Poggesi
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2017
Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
MA Marques, GA de Oliveira
Frontiers in physiology 2016
Liver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytes
SM Behunin, MA Lopez-Pier, RM Mayfield, CA Danilo, Y Lipovka, C Birch, S Lehman, JC Tardiff, CC Gregorio, JP Konhilas
Archives of Biochemistry and Biophysics 2016
Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility
Y Cheng, M Regnier
Archives of Biochemistry and Biophysics 2016
In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models
Z Jian, YJ Chen, R Shimkunas, Y Jian, M Jaradeh, K Chavez, N Chiamvimonvat, JC Tardiff, LT Izu, RS Ross, Y Chen-Izu, GC Fan
PloS one 2016
Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy
JO Ormerod, MP Frenneaux, MV Sherrid
Nature Reviews Cardiology 2016
Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy
C Yang, C Zhang, J Yuan, J Cui, S Liu, F Hu, W Yang, X Bi, S Qiao
Biology of sex differences 2016
Animal and in silico models for the study of sarcomeric cardiomyopathies
DJ Duncker, J Bakkers, BJ Brundel, J Robbins, JC Tardiff, L Carrier
Cardiovascular Research 2015
ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease
V Sequeira, A Najafi, PJ Wijnker, CG Remedios, M Michels, DW Kuster, J der Velden
Proceedings of the National Academy of Sciences 2015
Muscle dysfunction in hypertrophic cardiomyopathy: What is needed to move to translation?
C Poggesi, CY Ho
Journal of Muscle Research and Cell Motility 2014
Hypertrophic cardiomyopathy: a heart in need of an energy bar?
S Vakrou, MR Abraham
Frontiers in physiology 2014
Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy
AE Messer, SB Marston
Frontiers in physiology 2014
Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
R Coppini, CY Ho, E Ashley, S Day, C Ferrantini, F Girolami, B Tomberli, S Bardi, F Torricelli, F Cecchi, A Mugelli, C Poggesi, J Tardiff, I Olivotto
Journal of the American College of Cardiology 2014
Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy
W Song, PG Vikhorev, MN Kashyap, C Rowlands, MA Ferenczi, RC Woledge, K MacLeod, S Marston, NA Curtin
American journal of physiology. Heart and circulatory physiology 2013
ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)
A Güçlü, T Germans, ER Witjas-Paalberends, GJ Stienen, WP Brouwer, HJ Harms, JT Marcus, AB Vonk, W Stooker, A Yilmaz, P Klein, JM Berg, J Kluin, FW Asselbergs, AA Lammertsma, P Knaapen, AC van Rossum, J der Velden
Netherlands Heart Journal 2013
WIF1 causes dysfunction of heart in transgenic mice
D Lu, W Dong, X Zhang, X Quan, D Bao, Y Lu, L Zhang
Transgenic Research 2013
Magnetic resonance imaging and spectroscopy of the murine cardiovascular system
A Akki, A Gupta, RG Weiss
American journal of physiology. Heart and circulatory physiology 2013
Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific
H He, K Hoyer, H Tao, R Rice, J Jimenez, JC Tardiff, JS Ingwall
The Journal of Physiology 2012
Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits
PJ Wijnker, V Sequeira, DW Kuster, J van der Velden
Antioxidants & Redox Signaling 2012
Mechanisms of disease: hypertrophic cardiomyopathy
N Frey, M Luedde, HA Katus
Nature Reviews Cardiology 2011
Compromised Myocardial Energetics in Hypertrophied Mouse Hearts Diminish the Beneficial Effect of Overexpressing SERCA2a
I Pinz, R Tian, D Belke, E Swanson, W Dillmann, JS Ingwall
The Journal of biological chemistry 2011
Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder
JC Tardiff, J Robbins, C Seidman, H Watkins
Circulation research 2011
Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts
R Rice, P Guinto, C Dowell-Martino, H He, K Hoyer, M Krenz, J Robbins, JS Ingwall, JC Tardiff
Journal of Molecular and Cellular Cardiology 2010
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
S Huke, BC Knollmann
Journal of Molecular and Cellular Cardiology 2010
Abnormal heart rate regulation in murine hearts with familial hypertrophic cardiomyopathy-related cardiac troponin T mutations
J Jimenez, JC Tardiff
American journal of physiology. Heart and circulatory physiology 2010
Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice
BJ Biesiadecki, K Tachampa, C Yuan, JP Jin, PP de Tombe, RJ Solaro
The Journal of biological chemistry 2010
Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy
M Luedde, U Flögel, M Knorr, C Grundt, HJ Hippe, B Brors, D Frank, U Haselmann, C Antony, M Voelkers, J Schrader, P Most, B Lemmer, HA Katus, N Frey
Journal of Molecular Medicine 2009
Role of Animal Models in HCM Research
R Shephard, C Semsarian
Journal of Cardiovascular Translational Research 2009
Mechanical and Energetic Consequences of HCM-Causing Mutations
C Ferrantini, A Belus, N Piroddi, B Scellini, C Tesi, C Poggesi
Journal of Cardiovascular Translational Research 2009
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy
SW Luckey, LA Walker, T Smyth, J Mansoori, A Messmer-Kratzsch, A Rosenzweig, EN Olson, LA Leinwand
Journal of Molecular and Cellular Cardiology 2009
Insights into the kinetics of Ca2+-regulated contraction and relaxation from myofibril studies
R Stehle, J Solzin, B Iorga, C Poggesi
Pflügers Archiv - European Journal of Physiology 2009
Myofilament Calcium Sensitization Causes Susceptibility To Cardiac Arrhythmia
Franz Baudenbacher*, Tilmann Schober#, Jose Renato Pinto@, Veniamin Y. Sidorov*, Fredrick Hilliard#, R. John Solaro%, James D. Potter@, Björn C. Knollmann#&
Journal of Clinical Investigation 2008
Energy metabolism in heart failure and remodelling
JS Ingwall
Cardiovascular Research 2008
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils: Human cardiac myofibril mechanics and R403Q myosin
A Belus, N Piroddi, B Scellini, C Tesi, GD Amati, F Girolami, M Yacoub, F Cecchi, I Olivotto, C Poggesi
The Journal of Physiology 2008
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
B Strijack, V Ariyarajah, R Soni, DS Jassal, CR Greenberg, R McGregor, A Morris
Journal of Cardiovascular Magnetic Resonance 2008
R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts
H He, MM Javadpour, F Latif, JC Tardiff, JS Ingwall
Biophysical Journal 2007
Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca 2+ sensitivity increase: Increasing myofilament Ca 2+ sensitivity limits inotropic responsiveness
SG Sirenko, JD Potter, BC Knollmann
The Journal of Physiology 2006
Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms: Troponin T mutation and tension cost
ML Tschirgi, I Rajapakse, M Chandra
The Journal of Physiology 2006
Myofibrillar remodelling in cardiac hypertrophy, heart failure and cardiomyopathies
Machackova J, Barta J, Dhalla NS
The Canadian journal of cardiology 2006
Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes
JC Tardiff
Heart Failure Reviews 2005
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice
BR Ertz-Berger, H He, C Dowell, SM Factor, TE Haim, S Nunez, SD Schwartz, JS Ingwall, JC Tardiff
Proceedings of the National Academy of Sciences 2005
Structural based insights into the role of troponin in cardiac muscle pathophysiology
MX Li, X Wang, BD Sykes
Journal of Muscle Research and Cell Motility 2004
Two Functionally Identical Modular Enhancers in Drosophila Troponin T Gene Establish the Correct Protein Levels in Different Muscle Types
JA Mas, E García-Zaragoza, M Cervera
Molecular biology of the cell 2004
Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair
K Schwartz
Journal of Clinical Investigation 2003

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts